Company / Operating Cash Flow per Share
CHINA PHARMA HOLDINGS, INC. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.05
FY2025
5-year range
-$0.47 / $0.05
FY2021-FY2025
Trend
+169.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-0.47 in FY2023 to $0.08 in FY2016.
Based on SEC 10-K filings.
0.05 in FY2025 with a 5-year CAGR of +26.6%.
Improved from $-0.47 to $0.05 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +26.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 169.0% year-over-year.
- Peak operating cash flow per share was recorded in FY2016.
- Lowest operating cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.05 | +169.0% |
| FY2024 | -$0.07 | +85.9% |
| FY2023 | -$0.47 | -439.8% |
| FY2022 | -$0.09 | -9230.8% |
| FY2021 | -$0.00 | -106.6% |
| FY2020 | $0.01 | -67.7% |
| FY2019 | $0.04 | +123.7% |
| FY2018 | $0.02 | -70.9% |
| FY2017 | $0.07 | -13.6% |
| FY2016 | $0.08 | -45.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026